Be a PRO & get up to 50% off on select brands. Explore Now

Equity MF inflows dip in April; will pick up once COVID situation eases, say experts

Fund of Funds offerings remain attractive for investors as global equities continue to rise. Overseas Fund of Funds investing saw net inflows of Rs 695.34 crore in April.

May 12, 2021 / 10:12 AM IST

First the good news—equity mutual funds continued to see inflow for the second successive month in April. In the not so good news, the inflow of Rs 3,437.37 crore during the month was 60 percent lower than Rs 9,115.12 crore in March.

Fund managers, however, are not too worried. They see the decline as a result of the rise in COVID-19 cases in the country and the lockdown-like restriction in various states. The net inflows—investments exceeding redemptions—will pick up once the coronavirus situation eases, they say.

“Most of the equity fund categories witnessed net inflows except for the multi-cap fund, dividend yield fund, value fund/contra fund and ELSS funds,” Himanshu Srivastava, Associate Director–Manager Research, Morningstar India, said.

“The quantum of redemption was almost the same as the last month. The fund mobilised was lower than that in March, suggesting some of the investors would have preferred to stay on the sidelines until more clarity emerges around the impact of the second wave of the pandemic on the economy,” he said.

Some investors would also have held back in anticipation of a market correction given the ongoing concerns, he said.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Also Read: Equity fund inflows continue in April; bond schemes, Gold ETFs in demand

The other categories which received significant flows were mid and largecaps. Thematic schemes and mid-cap schemes got inflows of Rs 1,705 crore and Rs 958 crore, respectively

Total assets under management (AUM) for April ended at Rs.32.38 lakh crore, a minor increase in comparison to the fall seen in March where it stood at Rs 32.17 lakh crore.

Contributions through systematic investment plans (SIPs) also slipped in April to Rs 8,590 crore from Rs 9,182 crore in the previous month. In April, the number of SIP accounts outstanding registered was at 3.79 crores compared to 3.72 crore in the previous month, which is a positive sign.

“The net inflows into equity funds have continued in April, which is very encouraging. The SIP numbers have remained robust and the addition of SIP folios also have been very healthy,” G Pradeepkumar CEO Union AMC said.

“Given the expensive valuations, we have been recommending asset allocation funds such as Balanced Advantage Funds (BAF) for investors. This category has also seen meaningful inflows. We expect the flows to pick up pace once the pandemic is brought under control through increased levels of vaccination and other measures,” he said.

Global funds

The Nifty closed flat with a negative bias in April and remained volatile throughout the month compared to the 5 percent rise seen in the US Market (S&P 500).

Fund of Funds offerings continued to interest investors as global equities rise. Fund of Funds investing overseas saw net inflows of Rs 695.34 crore in April compared to Rs 1,776 crore in March.

“The interesting trend of money being allocated to relatively newer categories like international funds and domestic index funds continues to gain traction,” Aashish Somaiyaa, Chief Executive Officer-White Oak Capital said.

Gopal Kavalireddi, Head of Research at FYERS, also said that new Fund of Funds offerings continue to attract investors. “With the second wave of the coronavirus pandemic putting pressure on citizens to hold a higher emergency corpus for medical needs, investor interest is a tad down and can be expected to recover in the waning phase of this health scare,” he said.

Disclaimer: The views and investment tips expressed by experts on are their own and not those of the website or its management. advises users to check with certified experts before taking any investment decisions.
Kshitij Anand is the Editor Markets at Moneycontrol.

stay updated

Get Daily News on your Browser